B-Cell Malignancies—Expert Guidance on BTK Inhibitors for Today’s Clinic

In this clinic-focused program review the latest data on current and emerging strategies leveraging BTK inhibitors to manage MCL CLL and other B-cell malignancies with an on-demand Webcast capturing expert discussion from the 2019 meeting in Chicago. Then download the meeting slidesets to help guide your treatment decisions.

Share

Program Content

No activities added yet

No activities added yet

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

AstraZeneca